Login / Signup
Are We Ready to Include Organ-Impaired Patients in Oncology Trials? A Clinical Pharmacology Perspective on Recent Recommendations.
Joanna C Masters
Peter H Wiernik
Published in:
Journal of clinical pharmacology (2018)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical practice